ACA
GMAB icon

American Capital Advisory’s Genmab GMAB Stock Holding History

American Capital Advisory’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.26K Buy
+46
New +$1.22K ﹤0.01% 742
2026
Q1 		– Sell
-8
Closed -$247 – 1168
2025
Q4 		$247 Hold
8
– – ﹤0.01% 895
2025
Q3 		$246 Buy
+8
New +$195 ﹤0.01% 846

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

American Capital Advisory's GMAB Position: Q2 2026 in Review

American Capital Advisory opened a new position in Genmab (GMAB) in Q2 2026: 46 shares worth $1.26K. The stake represents ﹤0.01% of the portfolio and ranks #742 among its holdings. This is a return to the name: American Capital Advisory previously reported a position in GMAB as recently as Q4 2025.

American Capital Advisory first reported a position in GMAB in Q3 2025 and has held it in 3 quarters since. 289 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • American Capital Advisory held 46 shares of Genmab worth $1.26K as of Q2 2026.
  • Genmab was a new American Capital Advisory position in Q2 2026.
  • Genmab made up ﹤0.01% of American Capital Advisory's portfolio in Q2 2026, its #742 holding.
  • American Capital Advisory first reported a position in Genmab in Q3 2025 and has held it in 3 quarters since.
  • 289 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on American Capital Advisory's 13F filing for Q2 2026, filed 28 Jul 2026.